Kaiser Permanente gives UCLA Hispanic physician recruitment program $2 million

NewsGuard 100/100 Score

Kaiser Permanente is giving the University of California-Los Angeles a $2 million grant to fund a program that recruits foreign-trained doctors to practice in U.S. Hispanic neighborhoods, United Press International reports.

The International Medical Graduate Program will help Latin American medical school graduates pass U.S. licensing exams. The students will work in family medicine residency programs in California, according to Kaiser Permanente.

The goal is to increase the number of doctors in underserved, Spanish-speaking communities in California. According to Patrick Dowling, chair of the UCLA Department of Family Medicine, California will face a shortage of up to 17,000 physicians by 2015.

Dowling said about 2,500 physicians who were trained in Latin America are legal residents in California but cannot practice medicine in the U.S. The program is "committed to helping these skilled individuals navigate the road to licensure," Dowling said (United Press International, 5/5).

Please note: The Kaiser Family Foundation is not associated with Kaiser Permanente or Kaiser Industries.


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Balancing efficacy and safety: The challenges of mRNA drugs and vaccines in modern medicine